Application of risk factors for venous thromboembolism in patients with multiple myeloma starting chemotherapy, a real‐world evaluation

INTRODUCTION: Within the first year of diagnosis, up to 1 in 3 multiple myeloma (MM) patients will experience a venous thromboembolism (VTE). The International Myeloma Working Group (IMWG) has thromboprophylaxis guidelines that stratify patients into low or high risk for thrombosis and subsequently...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Hailey A., Brown, Alexandra R., Mahnken, Jonathan D., Shireman, Theresa I., Webb, Carol E., Lipe, Brea C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346245/
https://www.ncbi.nlm.nih.gov/pubmed/30585435
http://dx.doi.org/10.1002/cam4.1927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346245/
https://www.ncbi.nlm.nih.gov/pubmed/30585435
http://dx.doi.org/10.1002/cam4.1927

Ejemplares similares